Sandoz Unveils $400m+ Investment In Slovenian Biosimilars Plant

Lendava Biologics Facility Is Expected To Become Fully Operational By 2026

Mar 09 2023

• By David Wallace

Sandoz has unveiled plans to invest at least $400m in a biologics production facility in Slovenia • Source: Shutterstock

More from Manufacturing

More from Business